{
    "nctId": "NCT00645866",
    "briefTitle": "Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer",
    "officialTitle": "A Neo-Adjuvant Study of Sequential Epirubicin and Docetaxel in Combination With Capecitabine in Patients With Locally Advanced Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "N/A",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 47,
    "primaryOutcomeMeasure": "Pathologic response rate",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Histologically or cytologically confirmed breast cancer\n\n  * Stage IIIA or IIIB disease (T3 N1 M0, T4 N1 M0, any T N2/N3 M0)\n* Bidimensionally measurable or evaluable disease\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Menopausal status not specified\n* ECOG performance status 0-2\n* Platelet count \u2265 100,000 cells/\u03bcL\n* Total bilirubin normal\n* Hemoglobin \u2265 8.0 g/dL\n* ANC \u2265 1,000 cells/\u03bcL\n* AST and ALT \u2264 2.5 times upper limit of normal\n* Creatinine clearance \u2265 50 mL/min and serum creatinine normal\n* Life expectancy \u2265 3 months\n* No uncontrolled infection\n* No chronic debilitating disease\n* No lack of physical integrity of the upper gastrointestinal tract\n* Able to swallow tablets\n* No malabsorption syndrome\n* No clinically significant cardiac disease not well controlled with medication (e.g., congestive heart failure, symptomatic coronary artery disease and cardiac arrhythmias \\[New York Heart Association class III-IV heart disease\\] or myocardial infarction within the last 12 months)\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective contraception\n* No other malignancy within the past 5 years except for adequately treated basal cell or squamous cell skin cancer or adequately treated other noninvasive carcinomas\n* No peripheral neuropathy \u2265 grade 1\n\nPRIOR CONCURRENT THERAPY:\n\n* More than 4 weeks since prior major surgery and recovered\n* No prior chemotherapy regimens including adjuvant therapy\n* No organ allograft\n* No concurrent sorivudine or bruvidine\n* No other concurrent cytostatic, cytotoxic, immunomodulating agents, or radiotherapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}